Patents Assigned to Biomodifying, LLC
  • ANTI- MUC1-SEA ANTIBODIES
    Publication number: 20230085269
    Abstract: The present invention provides isolated monoclonal antibodies which bind to the MUC1 SEA domain. The invention also concerns the use of these antibodies in therapeutic and diagnostic methods.
    Type: Application
    Filed: March 11, 2021
    Publication date: March 16, 2023
    Applicants: BIOMODIFYING, LLC, Ramot at Tel-Aviv University Ltd.
    Inventors: Daniel Rubinstein, Daniel Wreschner
  • Anti-MUC1 ?/? antibodies
    Patent number: 8648172
    Abstract: The present invention provides antibodies that simultaneously bind the ?- and ?-subunits of an intact MUC1 protein, and methods for making and using such antibodies.
    Type: Grant
    Filed: November 16, 2011
    Date of Patent: February 11, 2014
    Assignees: Biomodifying, LLC, Ramot at Tel Aviv University Ltd.
    Inventors: Daniel B. Rubinstein, Daniel H. Wreschner
  • ANTI-MUC1 ALPHA/BETA ANTIBODIES
    Publication number: 20120207772
    Abstract: The present invention provides antibodies that simultaneously bind the ?- and ?-subunits of an intact MUC1 protein, and methods for making and using such antibodies.
    Type: Application
    Filed: November 16, 2011
    Publication date: August 16, 2012
    Applicants: BIOMODIFYING, LLC, RAMOT AT TEL AVIV UNIVERSITY, LTD.
    Inventors: DANIEL B. RUBINSTEIN, DANIEL H. WRESCHNER
  • Anti-Muc1 Alpha/Beta Antibodies
    Publication number: 20080226619
    Abstract: The present invention provides antibodies that simultaneously bind the ?- and ?-subunits of an intact MUC1 protein, and methods for making and using such antibodies.
    Type: Application
    Filed: January 27, 2006
    Publication date: September 18, 2008
    Applicants: Ramot At Tel Aviv University, Ltd., Biomodifying, LLC
    Inventors: Daniel B. Rubinstein, Daniel H. Wreschner